| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |